Product / Service Summary

Convenient and accesible cancer screening blood test that can be conducted at routine medical check-ups. Providing an easy way to all levels of society to detect cancer early, when it can be cured.

Life Science & Healthcare

Seed Stage




Canostix is developing a blood-based cancer test that combines photonics and machine learning, potentially beating liquid biopsy in regard to accuracy, cost and convenience. Starting with the five most common cancers, we create a constantly evolving software solution that upgrades commercially available hardware into top-of-the-line screening machines.


Established research cooperation in India - enabling much faster and more cost efficient development

Completed Proof-of-Concept with great results

Multidisciplinary team with decades of research and enterpreneurial experience

First company implementing population-scale clinical studies in the area of spectroscopic diagnostics

Canostix Team Members

  • company::verification::checklist::company.is_claimed
  • company::verification::checklist::startup_profile.is_qa_handelsregister
  • company::verification::checklist::startup_profile.is_qa_founded_in_germany
  • company::verification::checklist::startup_profile.is_qa_scaleable
  • company::verification::checklist::startup_profile.is_qa_innovative


Saving lives by revolutionizing cancer screening
  • 2018
  • 1-10 Employees
  • Canostix GmbH (limited)
  • Handelsregister
  • Berlin, DE